ストックスクリーナーアプリを入手
7.36
4.69%
0.33
プレマーケット:
7.52
0.16
+2.17%
前日終値:
$7.03
開ける：
$6.96
24時間の取引高:
42,525
Relative Volume:
0.36
時価総額：
$27.10M
収益：
-
当期純損益:
$-31.11M
株価収益率:
-4.8105
EPS:
-1.53
ネットキャッシュフロー:
$-28.18M
1週間 パフォーマンス:
-1.74%
1か月 パフォーマンス:
-1.08%
6か月 パフォーマンス:
-35.40%
1年 パフォーマンス:
-57.75%
1日の値動き範囲:
$6.96
$7.41
1週間の範囲:
$6.955
$7.54
52週間の値動き範囲:
$5.3495
$28.34
Tempest Therapeutics Inc Stock (TPST) Company Profile
名前
Tempest Therapeutics Inc
セクター
電話
415-798-8589
住所
2000 SIERRA POINT PARKWAY, BRISBANE
TPST を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
7.36 | 26.03M | 0 | -31.11M | -28.18M | -1.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-10 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-04-10 | ダウングレード | Scotiabank | Sector Outperform → Sector Perform |
| 2024-03-14 | 開始されました | Scotiabank | Sector Outperform |
| 2024-02-08 | 開始されました | Jefferies | Buy |
Tempest Therapeutics Inc (TPST) 最新ニュース
Real time alert setup for Tempest Therapeutics Inc. performanceInvestment Life Cycle Planning Summary - Newser
Why Tempest Therapeutics Inc. stock attracts strong analyst attentionFree Step-by-Step Trade Signal Implementation - Newser
Tempest Therapeutics Inc. stock chart pattern explainedSummary of Trade Cycles in 5-Year Range - Newser
What makes Tempest Therapeutics Inc. stock price move sharplySafe Momentum Strategy With Trend Analysis - Newser
Can machine learning forecast Tempest Therapeutics Inc. recoverySmart Stock Forecast Using AI Algorithms - Newser
Quantitative breakdown of Tempest Therapeutics Inc. recent moveSupport and Resistance Zone Summary Chart - Newser
Is it too late to sell Tempest Therapeutics Inc.Safe Momentum Strategy With Trend Analysis - Newser
Published on: 2025-08-10 01:25:41 - Newser
What technical models suggest about Tempest Therapeutics Inc.’s comeback - Newser
Multi factor analysis applied to Tempest Therapeutics Inc.Short Term Gain Strategy with AI Logic - Newser
Tempest Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayROI Focused Setup Screener With Exit Markers - Newser
Published on: 2025-08-09 23:28:19 - Newser
What data driven models say about Tempest Therapeutics Inc.’s futureBuy Signal Forecast With Short-Term Data - Newser
How Tempest Therapeutics Inc. stock performs during market volatilityFree Chart Breakout Buy Signal Detection - Newser
Tempest Therapeutics Inc. stock outlook for YEARReliable Setup Screener with Low Risk - Newser
Tempest Therapeutics Inc expected to post a loss of $2.60 a shareEarnings Preview - TradingView
Is Tempest Therapeutics Inc. stock bottoming outWeekly Hot Stocks Based on Volume Flow - Newser
Custom watchlist performance reports with Tempest Therapeutics Inc.Buy Candidate Summary Based on Fundamentals - Newser
Tempest Therapeutics (TPST) Expected to Announce Quarterly Earnings on Thursday - Defense World
Long term hold vs stop loss in Tempest Therapeutics Inc.Smart Forecast Signals from AI Models - Newser
Technical analysis overview for Tempest Therapeutics Inc. stockFree Buy Low Sell High Stock Watch - Newser
How Interest Rate Changes Impact Tempest Therapeutics Inc. Stock PerformanceAI Trading Forecast Based on Big Data - Newser
Morpheus-Liver Study: A New Horizon in Advanced Liver Cancer Treatment - TipRanks
What analysts say about Tempest Therapeutics Inc. stockCapitalize on market trends before they peak - Jammu Links News
Is it the right time to buy Tempest Therapeutics Inc. stockUnlock high-yield investment opportunities - Jammu Links News
Is Tempest Therapeutics Inc. stock overvalued or undervaluedAchieve consistent double-digit growth rates - Jammu Links News
Tempest Therapeutics Inc (TPST) 財務データ
収益
当期純利益
現金流量
EPS
0.24%
3.39%
大文字化:
|
ボリューム (24 時間):